Standard treatments for HD include antidopaminergic medications (ADMs) such as vesicular monoamine transporter 2 inhibitors (VMAT2 inhibitors) for chorea and off-label antipsychotics (neuroleptics), which may help reduce involuntary movements and behavioral symptoms4–7. This evidence concerns the gene SLC18A2 and Chorea.